Geolin, Mie C.
HRN: 16-81-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
CEFUROXIME 500MG (TAB)
02/28/2026
03/06/2026
IV
500 Mg
BID
Urinary Tract Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: